practitioners will recognize lactational atrophic vaginitis and be able to empower women with this condition to make the best treatment decisions for themselves and their families.

The global vaginal and vulval inflammatory diseases treatment market is poised for significant growth over the next decade, driven by a rising prevalence of gynecological conditions, expanding ...

Atrophic vaginitis is typically associated with the ... She called the birth center to report that the treatment was working, she was still nursing with no decrease in milk supply, and intercourse ...

Vaginal atrophy, often referred to as atrophic vaginitis, is a condition that affects many women ... and anxiety is crucial for providing effective treatment and support. Seeking medical advice, ...

The most common causes of postcoital bleeding are related to the genital tract, including vaginal lacerations, vaginal trauma, vaginal atrophy, vaginitis ... provider for a diagnosis and to discuss ...

FDA approves the first treatment for KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC), offering new hope for ...

Geographic atrophy (GA) is characterized by progressive ... monitoring of biomarkers associated with GA and their response to treatment; and evaluate findings from the clinical trials of novel ...

Adult and pediatric generalized myasthenia gravis patients have a new, longer acting option for treatment called Imaavy.

Boehringer Ingelheim announces the start of the JADE phase II clinical study (NCT06769048), investigating the efficacy and safety of BI 1584862 as a potential first-in-class treatment for geographic ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and most expensive level of clinical testing. The drugmaker said Tuesday ...